直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

The USPTO May Intervene on an Appeal in Its Own Right

April 12, 2018

Authored and Edited by Christina Ji-Hye Yang; Lillian M. Robinson; Elizabeth D. Ferrill

In Knowles Elecs. LLC v. Iancu, No. 2016-1954 (Fed. Cir. April 6, 2018), the Federal Circuit affirmed a PTAB decision in an inter partes reexamination, which affirmed the examiner’s findings that the claims of U.S. Patent No. 8,018,049 were unpatentable as anticipated and obvious.  The issue on appeal was whether the PTO has standing to intervene to defend its decision, even when the requestor has withdrawn from the case.

The majority held that the PTO Director has standing because “[t]he director of the USPTO has an unconditional statutory right to intervene in an appeal from a PTAB decision,” even when the petitioner withdraws on appeal.  The Federal Circuit then affirmed the PTAB’s claim construction of a term, which was nearly identical to the Court’s construction in another case, holding that it was consistent with the term’s broadest and reasonable interpretation.  The Federal Circuit also held that the PTAB did not rely on a new ground of rejection in its obviousness analysis and that Knowles had a fair opportunity to respond to the rejection.

Judge Newman dissented, contending that the PTO Director failed to meet the standing requirements of Article III.  Judge Newman also noted that if important new evidence is introduced on appeal, the case should be remanded to the agency to give the other party an opportunity to respond.

Tags

Patent Trial and Appeal Board (PTAB)

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Contacts

Christina Ji-Hye Yang
Partner
Washington, DC
+1 202 408 4465
Email
Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2018 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP